Moderna | MRNA - Selling And Administration Expenses


Moderna reported $216M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Acadia Pharmaceuticals USD 148.57M 12.22M Jun/2026
Agios Pharmaceuticals USD 38.46M 4.51M Mar/2026
Alnylam Pharmaceuticals USD 347.92M 65.41M Jun/2026
Amgen USD 1.72B 134M Jun/2026
Arrowhead Research USD 46.63M 4.88M Jun/2026
Biogen USD 709.7M 155.4M Jun/2026
BioMarin Pharmaceutical USD 395.55M 137.27M Jun/2026
Celltrion KRW 9.32B 3.39B Mar/2026
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Dianthus Therapeutics USD 12.47M 5.89M Mar/2026
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Gilead Sciences USD 1.52B 70M Jun/2026
GlaxoSmithKline GBP 2.19B 75M Jun/2026
Incyte USD 351.73M 23.64M Jun/2026
Ionis Pharmaceuticals USD 130.07M 20.92M Jun/2026
Kangmei Pharma CNY 237.06M 37.35M Mar/2026
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Moderna USD 216M 43M Jun/2026
Organigram Holdings CAD 22.01M 14.28M Mar/2026
Ovoca Bio EUR 617K 15K Dec/2025
Pharma Mar EUR 17.12M 1.82M Jun/2026
Puma Biotechnology USD 16.82M 8.15M Sep/2024
Qiagen NV USD 142.33M 60K Jun/2026
Regeneron Pharmaceuticals USD 662.1M 14.4M Jun/2026
Sangamo BioSciences USD 9.64M 1.83M Jun/2024
Sarepta Therapeutics USD 107.6M 53.57M Jun/2026
Sartorius EUR 221.3M 0 Jun/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Tilray USD 24.85M 1.7M Sep/2025
Ultragenyx Pharmaceutical USD 88M 1000K Mar/2026
United Therapeutics USD 206.7M 50.1M Jun/2026
Vertex Pharmaceuticals USD 582.2M 88.5M Jun/2026
Zealand Pharma A/S 104M 12.19M Mar/2026
Zz Pientze Pharmaceu CNY 214.31M 42.4M Mar/2026